Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD

Thorax

Volumn 55, Issue 10, 2000, Pages 848-853

  Maltais, François ^a   LeBlanc, Pierre ^a   Whittom, François ^a   Simard, Clermont ^b   Marquis, Karine ^a   Bélanger, Marthe ^a   Breton, Marie Josée ^a   Jobin, Jean ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Exercise; Oxidative enzymes

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CITRATE SYNTHASE; MITOCHONDRIAL ENZYME;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXYGEN CONSUMPTION; OXYGEN SATURATION; PRIORITY JOURNAL; VASTUS LATERALIS MUSCLE;

3-HYDROXYACYL COA DEHYDROGENASES; AGED; CITRATE (SI)-SYNTHASE; EXERCISE; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; VITAL CAPACITY;

EID: 0033802131     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.10.848     Document Type: Article

References (34)

1. 1 Hughes RL, Katz. H, Sahgal V, et al. Fiber size and energy metabolites in five separate muscles from patient's with chronic obstructive lung disease. Respiration 1983;44:321-8.
2. 2 Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. J Eur Respir J 1990;3:192-6.
3. 3 Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Comparison with normal subjects and effects of exercise training. Med Sci Sports Exerc 1998;30: 1467-74.
4. 4 Hildebrand IL, Sylvén C, Esbjornsson M, et al. Does hypoxaemia induce transformations of fiber types? Acta Physiol Scand 1991;141:435-9.
5. 5 Satta A, Migliori GB, Spanevello A, et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997;10:2853-60.
6. 6 Maltais F, Simard AA, Simard C, et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996;153:288-93.
7. 7 Jakobsson P, Jorfeldt L, Henriksson J, Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:374-7.
8. 8 Hamilton AL, Killian KJ, Summers E, et al. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152:2021-31.
9. 9 Maltais F, Sullivan MJ, Leblanc P, et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J 1999;13:850-4.
10. 10 Richardson RS, Sheldon J, Poole DC, et al. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:881-5.
11. 11 Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 1984;56:831-8.
12. 12 Casaburi R, Patessio A, Ioli F, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991;143:9-18.
13. 13 Maltais F, Leblanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:442-7.
14. 14 Saltin B, Henriksson J, Nygaard E, et al. Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runners. Ann NY Acad Sci 1977;301:3-29.
15. 15 Knudson RJ, Slatin RC, Lebowitz MD, et al. The maximal expiratory flow-volume curve. Normal standards, variability and effects of age. Am Rev Respir Dis 1976;113:587-600.
16. 16 Goldman HI, Becklake MR. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc 1959;79:454-67.
17. 17 Cotes JE, Hall AM. The transfer factors for the lung; normal values in adults. In: Arcangeli P, ed. Normal values for respiratory function in man. Torino: Panminerva Medica, 1970: 327-43.
18. 18 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
19. 19 Bergström J. Muscle electrolytes in man. Determination by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients and patients with chronic diarrhoea. Scand J Clin Lab Invest 1962;14:1-110.
20. 20 Zammit VA, Newsholme EA. The maximum activities of hexokinase, phosphorylase, phosphofructokinase, glycerol phosphate dehydrogenase, lactate desydrogenase, octopine dehydrogenase, phosphoenolpyruvate carboxykinase, nucleoside diphosphatekinase, glutamate-oxalate transaminase and arginine kinase in relation of carbohydrate utilisation in muscle from invertebrates. Bioehem J 1976,160: 447-62.
21. 21 Srere PA. Citrate synthase. Methods Enzymol 1969;13:3-11.
22. 22 Weber KT, Janicki JS. Lactate production during maximal and submaximal exercise in patients with chronic heart failure. J Am Coll Cardiol 1985;6:717-24.
23. 23 Clark TJH, Freedman S, Campbell EJM, et al. The ventilatory capacity of patients with chronic airway obstruction. Clin Sci 1969;36:307-16.
24. 24 Saltin B, Gollnick PD. Skeletal muscle adaptability: significance for metabolism and performance. In: Peachey LD, ed. The handbook of physiology: the skeletal muscle system. Bethesda, MD: American Physiological Society, 1982: 555-631.
25. 25 Jakobsson P, Jorfeldt L, von Schenck H. Fat metabolism and its response to infusion of insulin and glucose in patients with advanced chronic obstructive pulmonary disease. Clin Physiol 1995;15:319-29.
26. 26 Sauleda J, Garcia-Palmer F, Wiesner RJ, et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1413-7.
27. 31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. Am Rev Respir Dis 1992;146:1019-24.
28. 28 Westerblad H, Lee JA, Lannergren J, et al. Cellular mechanisms of fatigue in skeletal muscle. Am J Physiol 1991;261: C195-209
29. 29 Maltais F, Jobin J, Sullivan MJ, et al. Metabolic and hemodynamic responses of the lower limb during exercise in patients with COPD. J Appl Physiol 1998;84:1573-80.
30. 30 Similowski T, Yan S, Gauthier AP, et al. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991;325:917-23.
31. 31 Dodd DS, Brancatisano T, Engel LA. Chest wall mechanics during exercise in patients with severe chronic air-flow obstruction. Am Rev Respir Dis 1984;129:33-8.
32. 32 O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. Am Rev Respir Dis 1993;148:1351-7.
33. 33 Murariu C, Ghezzo H, Milic-Emili J, et al. Exercise limitation in obstructive lung disease. Chest 1998;114:965-8.
34. 34 Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with airflow limitation. Am Rev Respir Dis 1992;146:935-40.